EXCLUSIVE: Inside VedaBio - The Breakthrough That Could Redefine Point-of-Care Diagnostics
In this episode of Diagnosing Dx, I sit down with Frédéric D. Sweeney, President & CEO of VedaBio, the company pioneering a completely new class of molecular diagnostics — one that detects DNA and RNA without amplification while maintaining full clinical sensitivity in under 10 minutes.
We explore how this platform could transform urgent care, decentralised testing, and infectious disease workflows — and why VedaBio believes the next leap in molecular diagnostics won’t come from making PCR faster, but from removing amplification entirely.
Frédéric also opens up about the realities of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.